ArticleBiometrics2005
MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.
Article in Biometrics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review.Epidemiology and health · 2022Pooled it
- Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening.Scientific reports · 2020Trial
- Estimating Transition Probabilities Across the Alzheimer's Disease Continuum Using a Nationally Representative Real-World Database in the United States.Neurology and therapy · 2023Article
- Estimating the Length of the Preclinical Detectable Phase for Open-Angle Glaucoma.JAMA ophthalmology · 2023Article
- Inference of Onset Age of Preclinical State and Sojourn Time for Breast Cancer.Medical research archives · 2022Article
- When to initiate cancer screening exam?Statistics and its interface · 2022Article
- Estimation of Preclinical State Onset Age and Sojourn Time for Heavy Smokers in Lung Cancer.Statistics and its interface · 2022Article
- Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer.Medical research archives · 2021Article
- Problems in the Estimation of the Key Parameters using MLE in Lung Cancer Screening.Journal of clinical research and reports · 2020Article
- Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial.Journal of healthcare informatics research · 2018Article
- A Bayesian model for estimating multi-state disease progression.Computers in biology and medicine · 2017Article
- A Bayesian nonlinear mixed-effects disease progression model.Journal of biometrics & biostatistics · 2015Article
- Bayesian lead time estimation for the Johns Hopkins Lung Project data.Journal of epidemiology and global health · 2013Article
- A limited Review of Over Diagnosis Methods and Long Term Effects in Breast Cancer Screening.Oncology reviews · 2011Article
- Sojourn time and lead time projection in lung cancer screening.Lung cancer (Amsterdam, Netherlands) · 2011Article
- Inferences for the Lead Time in Breast Cancer Screening Trials under a Stable Disease Model.Cancers · 2011Article
- Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.Cancer epidemiology · 2010Article
- A projection of benefits due to fecal occult blood test for colorectal cancer.Cancer epidemiology · 2009Article
- Estimating key parameters in FOBT screening for colorectal cancer.Cancer causes & control : CCC · 2009Article
- Bayesian inference for the lead time in periodic cancer screening.Biometrics · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This article extends previous probability models for periodic breast cancer screening examinations. The specific aim is to provide statistical inference for age dependence of sensitivity and the transition probability from the disease free to the preclinical state. The setting is a periodic screening program in which a cohort of initially asymptomatic women undergo a sequence of breast cancer screening exams. We use age as a covariate in the estimation of screening sensitivity and the transition probability simultaneously, both from a frequentist point of view and within a Bayesian framework. We apply our method to the Health Insurance Plan of Greater New York study of female breast cancer and give age-dependent sensitivity and transition probability density estimates. The inferential methodology we develop is also applicable when analyzing studies of modalities for early detection of other types of progressive chronic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.